REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Apteka Sterdyn Tomasz Kolanek sp. k. (Poland)

Main Activities: Department Stores
Secondary Activities: Pharmaceutical Preparation Manufacturing | All Other Specialty Food Stores | Pharmacies and Drug Stores | Cosmetics, Beauty Supplies, and Perfume Stores | Electronic Shopping and Mail-Order Houses | All Other Nondepository Credit Intermediation | Advertising Agencies | Marketing Research and Public Opinion Polling
Full name: Apteka Sterdyn Tomasz Kolanek sp. k. Profile Updated: August 23, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Apteka Sterdyn Tomasz Kolanek sp. k. is a company in Poland, with a head office in Sterdyn. It operates in the Department Stores sector. Apteka Sterdyn Tomasz Kolanek sp. k. was incorporated on September 19, 2017.

Headquarters
Ul. Prof. Kazimierza Krysiaka 10
Sterdyn; Mazowieckie; Postal Code: 08-320

Contact Details: Purchase the Apteka Sterdyn Tomasz Kolanek sp. k. report to view the information.

Basic Information
Financial Auditors:
Purchase the Apteka Sterdyn Tomasz Kolanek sp. k. report to view the information.
Incorporation Date:
September 19, 2017
Key Executives
Purchase this report to view the information.
Associate Partner
Purchase this report to view the information.
Limited Partner
Company Performance
Financial values in the chart are available after Apteka Sterdyn Tomasz Kolanek sp. k. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Total assets
0%
Total equity
0%

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo